TGFB1 and acute myeloid leukemia: In this context, Hong et al. analyzed the levels of total proteins and transforming growth factor-beta1 (TGFb-1), in plasma EVs from 16 newly diagnosed AML patients and from other patients during chemotherapy (n = 9 post induction, n = 10 during consolidation, and n = 5 long-term remission chemotherapy).